

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York


(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced its intention to cancel its shares from trading on AIM on Monday,...


TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill


(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma updated the market on patents for its lead development candidate 'Oleogel-S...


IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition


IN BRIEF: Amryt hikes guidance on record second quarter results


(Sharecast News) - Amryt Pharma reported record second quarter results on Friday, raising its full-year guidance, as revenue in the three months ended...


EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt